Vaughan, 2004 - Google Patents
Identifying Genes Influencing Bone Mineral DensityVaughan, 2004
View PDF- Document ID
- 10873935161929288833
- Author
- Vaughan T
- Publication year
External Links
Snippet
In summary, this study investigated the role of novel polymorphisms and rare variants of the RUNX2 gene in influencing BMD, fracture and markers of bone turnover. Two common polymorphisms were identified within the polyA repeat: an 18 base pair deletion and a …
- 108090000623 proteins and genes 0 title description 6
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Panoutsopoulou et al. | Advances in osteoarthritis genetics | |
| Langdahl et al. | Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures | |
| Spector et al. | Association between a variation in LRCH1 and knee osteoarthritis: a genome‐wide single‐nucleotide polymorphism association study using DNA pooling | |
| JP2003514513A (en) | Polymorphism in the closo gene | |
| e Salute | Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones | |
| Hadi | The impact of vitamin D receptor gene polymorphism (rs2228570) in osteoarthritis in Iraqi women | |
| US7407753B2 (en) | Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis | |
| Kerkhof et al. | A genome-wide association study identifies a locus on chromosome 7q22 to influence susceptibility for osteoarthritis | |
| Vaughan | Identifying Genes Influencing Bone Mineral Density | |
| Beamer et al. | BMD regulation on mouse distal chromosome 1, candidate genes, and response to ovariectomy or dietary fat | |
| WO2006067056A1 (en) | Compositions and methods for treating mental disorders | |
| Horecka et al. | Association between single nucleotide polymorphisms of ATP2B1 gene and bone parameters of laying hens | |
| JP2002525074A (en) | Method for measuring susceptibility to bone damage by screening for polymorphisms in vitamin D receptor gene | |
| Stephens | Genetic and functional characterization of RUNX2 | |
| CA2343049A1 (en) | Combination of markers at the estrogen- and vitamin d-receptor genes or equivalents thereof to prognose a response to osteoporosis therapy | |
| Lecanda et al. | Impaired intramembranous bone formation in connexin43 null mice | |
| Vallejo Sefair | Maternal psychological distress and peripheral inflammation during pregnancy: associations with child neurodevelopment | |
| Grant | Studies on genetic susceptibility to osteoporosis: analysis of cis-acting sequences in the collagen type i [alpha] 1 gene | |
| US20060141526A1 (en) | Genetic marker for coronary artery disease | |
| Vallet | Study of RIN3: a susceptibility gene for Paget’s disease of bone | |
| Mangion | The localisation, fine mapping and search for the cherubism gene | |
| Duncan | The genetics of osteoporosis | |
| Mullin | Analysis of Candidate Genes Within the 3p14-p22 Region of the Human Genome for Association with Bone Mineral Density Phenotypes | |
| Watson | Investigating the Genetic Basis of Forms of Osteoarthritis | |
| Wang | Collagen IX: A molecular candidate for the pathogenesis of osteoporosis and frail bone microarchitecture |